{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["5ce78fac-c78c-4abe-a19d-e3c5bfefacbd", "Q1", 286278, "INTERNATIONAL COMMERCE DEVELOPMENT CORP", 176497, "AMPHASTAR PHARMACEUTICALS INC", 2008, "first_quarter", "2008-04-07T13:18:22-04:00", 170000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/5ce78fac-c78c-4abe-a19d-e3c5bfefacbd/\", \"filing_uuid\": \"5ce78fac-c78c-4abe-a19d-e3c5bfefacbd\", \"filing_type\": \"Q1\", \"filing_type_display\": \"1st Quarter - Report\", \"filing_year\": 2008, \"filing_period\": \"first_quarter\", \"filing_period_display\": \"1st Quarter (Jan 1 - Mar 31)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/5ce78fac-c78c-4abe-a19d-e3c5bfefacbd/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"170000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Gregory J. Newell, President of International Commerce Development Corporation\", \"dt_posted\": \"2008-04-07T13:18:22-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"4251 WATERFORD COURT\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"PROVO\", \"registrant_state\": \"UT\", \"registrant_zip\": \"84604\", \"registrant\": {\"id\": 286278, \"url\": \"https://lda.senate.gov/api/v1/registrants/286278/\", \"house_registrant_id\": 37002, \"name\": \"INTERNATIONAL COMMERCE DEVELOPMENT CORP\", \"description\": null, \"address_1\": \"4251 WATERFORD COURT\", \"address_2\": null, \"address_3\": null, \"address_4\": null, \"city\": \"PROVO\", \"state\": \"UT\", \"state_display\": \"Utah\", \"zip\": \"84604\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"MR. GREGORY J. NEWELL\", \"contact_telephone\": \"\", \"dt_updated\": \"2022-04-06T16:07:52.709464-04:00\"}, \"client\": {\"id\": 176497, \"url\": \"https://lda.senate.gov/api/v1/clients/176497/\", \"client_id\": 36, \"name\": \"AMPHASTAR PHARMACEUTICALS INC\", \"general_description\": null, \"client_government_entity\": false, \"client_self_select\": false, \"state\": \"CA\", \"state_display\": \"California\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"CA\", \"ppb_state_display\": \"California\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2007-08-06\"}, \"lobbying_activities\": [{\"general_issue_code\": \"PHA\", \"general_issue_code_display\": \"Pharmacy\", \"description\": \"Seeking general pharmaceuticals approvals for client from the FDA and EPA.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 2769, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"GREGORY\", \"nickname\": null, \"middle_name\": \"J\", \"last_name\": \"NEWELL\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 49, \"name\": \"Environmental Protection Agency (EPA)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["5ce78fac-c78c-4abe-a19d-e3c5bfefacbd"], "units": {}, "query_ms": 13.992112944833934, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}